Giuseppe Iatí

Prof. Giuseppe Iatí

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 April 2019 in Radiation Oncology
Verified
Journal Article
Open access
PDF file
RMRosa Morabito
Rosa Morabito
CAConcetta Alafaci
Concetta Alafaci
SPStefano Pergolizzi
Stefano Pergolizzi
APAntonio Pontoriero
Antonio Pontoriero
GIGiuseppe Iatí
Giuseppe Iatí
FGFrancesca Granata
Francesca Granata
The differential diagnosis between radiation necrosis, tumor recurrence and tumor progression is crucial for the evaluation of treatment response and treatment planning. The appearance of treatment-induced tissue necrosis on conventional Magnetic Resonance Imaging (MRI) is similar to brain tumor recurrence and it could be difficult to differentiate the two entities on follow-up MRI examinations. Dynamic Susceptibility Contrast-enhanced (DSC) and Dynamic Contrast-Enhanced (DCE) are MRI perfusion techniques that use an exogenous, intravascular, non-diffusible gadolinium-based contrast agent. The aim of this study was to compare the diagnostic accuracy of DSC and DCE perfusion MRI in the differential diagnosis between radiation necrosis and tumor recurrence, in the follow-up of primary and metastatic intra-axial brain tumors after Stereotactic RadioSurgery (SRS) performed with CyberKnife. A total of 72 enhancing lesions (57 brain metastases and 15 primary brain tumors) were analyzed with DCE and DSC, by means of MRI acquisition performed by 1,5 Tesla MR scanner. The statistical relationship between the diagnosis of tumor recurrence or radiation necrosis, decided according to clinicoradiologically criteria, rCBV and Ktrans was evaluated by the point-biserial correlation coefficient respectively. The statistical analysis showed a correlation between the diagnosis of radiation necrosis or recurrent tumor with Ktrans (rpb = 0.54, p < 0.001) and with rCBV (rpb = 0.37, p = 0.002). The ROC analysis of rCBV values demonstrated a good classification ability in differentiating radiation necrosis from tumour recurrence as well as the Ktrans. The optimal cut-off value for rCBV was k = 1.23 with 0.88 of sensitivity and 0.75 of specificity while for Ktrans was k = 28.76 with 0.89 of sensitivity and 0.97 of specificity. MRI perfusion techniques, particularly DCE, help in the differential diagnosis by tumor recurrence and radiation necrosis during the follow-up after radiosurgery.

30 January 2015 in SpringerPlus
Verified
Journal Article
Open access
PDF file
Alfredo ContiAlfredo Conti
Alfredo Conti
APAntonio Pontoriero
Antonio Pontoriero
FMFederica Midili
Federica Midili
GIGiuseppe Iatí
Giuseppe Iatí
CSCarmelo Siragusa
Carmelo Siragusa
CRCostantino De Renzis
Costantino De Renzis
Single fraction radiosurgery is conventionally precluded for lesions lying <2-3 mm of the anterior visual pathway because of the radiosensitivity of the optic nerve. We analyzed a series of 64 patients with “perioptic” meningiomas treated by CyberKnife multisession radiosurgery and hypofractionated stereotactic radiotherapy (hSRT). Between July 2007-May 2010, patients were treated using conventional multisession Cyberknife schemes (2–5 fractions) and results were retrospectively analyzed. A radiobiological model was then developed to estimate the best tumor control probability (TCP)/ normal tissue complication probability (NTCP) for these lesions. Resulting dose/fraction schemes were applied to patients treated between May 2010 and July 2014. Data were prospectively collected Twenty-five patients were included in the retrospective part of the study. Median tumor volume was 4.95 cc; median dose was 23.0 Gy and median number of fraction was 5 (range 2–5). No patient had visual deterioration at mean follow-up of 60 ± 12 months. Tumor control was achieved in all cases. Thirty-nine patients were treated according the radiobiology model and results prospectively analyzed. Median tumor volume was 7.5 cc, median dose 25.0 Gy and mean number of fraction 5 (range 3–15). No patient had visual deterioration or tumor progression at mean follow-up of 17 ± 10 months. Conventional multisession CyberKnife treatments (2–5 fractions) provided satisfactory results. Nonetheless, our estimation of TCP suggests the use of higher doses to grant long-term disease control. To achieve higher equivalent doses without significantly increasing the NTCP, we suggest the use of a greater number of fractions, moving to hSRT, in tumors in which the encasement of optic nerves is presumed.

1 June 2016 in Lung Cancer
Verified
Journal Article
Closed access
ASAlessandro Sindoni
Alessandro Sindoni
FMFabio Minutoli
Fabio Minutoli
APAntonio Pontoriero
Antonio Pontoriero
GIGiuseppe Iatí
Giuseppe Iatí
SBSergio Baldari
Sergio Baldari
SPStefano Pergolizzi
Stefano Pergolizzi

1 August 2020 in Radiotherapy and Oncology
Verified
Journal Article
Closed access
BJBarbara Alicja Jereczek-Fossa
Barbara Alicja Jereczek-Fossa
Matteo PepaMatteo Pepa
Matteo Pepa
GMGiulia Marvaso
Giulia Marvaso
ABAlessio Bruni
Alessio Bruni
MBMichela Buglione di Monale e Bastia
Michela Buglione di Monale e Bastia
VDVittorio Donato
Vittorio Donato

1 July 2017 in World Neurosurgery
Verified
Journal Article
Closed access
Alfredo ContiAlfredo Conti
Alfredo Conti
APAntonio Pontoriero
Antonio Pontoriero
GIGiuseppe Iatí
Giuseppe Iatí
FEFelice Esposito
Felice Esposito
ESEnrico Nastro Siniscalchi
Enrico Nastro Siniscalchi
FTFrancesco Tomasello
Francesco Tomasello

12 March 2019 in Oncology Research and Treatment
Verified
Journal Article
Open access
PDF file
PDPietro Delia
Pietro Delia
GSGiuseppe Sansotta
Giuseppe Sansotta
APAntonio Pontoriero
Antonio Pontoriero
GIGiuseppe Iatí
Giuseppe Iatí
SSSanta De Salvo
Santa De Salvo
SPStefano Pergolizzi
Stefano Pergolizzi
Background: Radiotherapy treatment for cervical cancer (CC) often induces side effects, including inflammation, dryness, dyspareunia. Considering its key role in the healing process, hyaluronic acid (HA) could be useful for the completion of radiotherapy. Objectives: The aim of this work was to evaluate the ability of HA to reduce the onset of side effects due to radiotherapy. Materials and Methods: In total, 180 women undergoing radiotherapy were randomized into two arms: controls and those treated with vaginal suppositories containing low-molecular-weight HA from day 1 of radiotherapy. The study lasted 5 weeks and was characterized by three visits: at baseline (T0), 15 days later (T1), and at the end of the radiotherapy cycle (T2). The onset of side effects, pain, safety, efficacy, acceptability of treatment, and compliance to the therapy were evaluated. Results: Patients in the control arm reported the onset and worsening of all symptoms with a moderate or severe grade at T2, whereas in the treatment arm almost 90% of patients reported the absence of symptoms or a mild grade. All patients in the treatment arm referred a lower intensity of pain on a visual analog scale compared with the control arm at T2 (6.85 ± 0.94 vs. 1.88 ± 1.02). Conclusions: HA was able to help vaginal mucosa healing during radiotherapy in patients with CC.